GlassScriptKavo Op30200300
Payments companies reported to CMS as associated with Kavo Op30200300. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Kavo Op30200300, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Kavo Op30200300
These are the largest totals companies reported as associated with Kavo Op30200300. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sarah Davies | Tarentum, PA | Oral & Maxillofacial Surgery | $108.81 |
| John Monterubio | St Louis, MO | Oral & Maxillofacial Surgery | $108.81 |
| Kelsey Menegotto | Indianapolis, IN | Oral and Maxillofacial Surgery | $108.81 |
| Eugenio Herbosa | St Louis, MO | Oral & Maxillofacial Surgery | $108.81 |
| Eric Smiga | Pittsburgh, PA | Oral & Maxillofacial Surgery | $108.81 |
| Thad Schulten | Louisville, KY | Oral and Maxillofacial Surgery | $108.81 |
| Adam Pitts | Nashville, TN | Oral & Maxillofacial Surgery | $108.81 |
| Joshua Everts | Alabaster, AL | Oral & Maxillofacial Surgery | $108.81 |
| Julie Montgomery | Dublin, OH | Dentist | $39.31 |
| Michael Repasky | Dublin, OH | Dentist | $39.31 |
Prescribed Kavo Op30200300?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.